Factors influencing non–adherence to chemotherapy: Perspective of Nigerian breast cancer survivors

  • Justin Agorye Ingwu* Department of Nursing Sciences, Faculty of Health Sciences and Technology, University of Nigeria, Nsukka, Nigeria
  • Chiamaka Idoko Department of Nursing Sciences, Faculty of Health Sciences and Technology, University of Nigeria, Nsukka, Nigeria
  • Chidinma Egbichi Israel Department of Nursing Sciences, Faculty of Health Sciences and Technology, University of Nigeria, Nsukka, Nigeria
  • Ijeoma Maduakolam Department of Nursing Sciences, Faculty of Health Sciences and Technology, University of Nigeria, Nsukka, Nigeria
  • Obiagele Madu Department of Nursing Sciences, Faculty of Health Sciences and Technology, University of Nigeria, Nsukka, Nigeria
Keywords: breast cancer survivors; chemotherapy; non–adherence

Abstract

Background and Aim: The use of chemotherapy for the treatment of breast cancer has experienced a rapid increase in recent years and this is expected to continue. The objectives of the study were to ascertain the patient-related factors, therapy-related factors, and health care system factors that influence non-adherence to chemotherapy among breast cancer survivors at University of Nigeria Teaching Hospital (UNTH), Enugu. Methods and Materials: The study design was a cross-sectional descriptive survey with a total population of 100 cancer survivors. The Breast cancer questionnaire was the instrument used for data collection. Results: The result of the study showed that financial constraint 61(61.0%) was the major patient-related factor that influences non-adherence to chemotherapy, Medication side effects (hair loss, loss of weight) 62(62.0%) and duration of treatment 50(50.0%) were the major therapy-related factors while unfavorable hour of clinic visit 40(40.0%) was the major health care related factor that influence non-adherence to chemotherapy. Conclusion: It was concluded that the federal government should re-implement the health care policy that allowed treatment free-of-charge at Nigerian government hospitals to those with malignancies and other chronic ailments to mitigate the burden of associated financial problems and encourage patients to seek orthodox medical care.

References

World Health Organization WHO (2012). Breast cancer; prevention and control.

Lawrence, N., Shulman,Walter, W. & Felicia, M. (2010); Breast cancer in developing countries; Opportunities for improved survival. Journal of oncology (2010);595167.

Global Health Estimate & WHO (2013). Breast cancer: prevention and control.

Globocan .(2008): Estimated cancer incidence, mortality and prevalence worldwide in 2012. Available from http:globocan.iarc.fr/Default.aspx[Accessed on 31 August, 2014].

WHO (2007). Cancer control: knowledge into action: WHO guide for effective programmes: early detection.

WHO (2008). The global burden of disease: 2004 update.

Adams, S.A., Butler, W.M., Fulton, J., Heiney, S.P., Williams, E.M., Delage, A.F., Khang, L. & Hebert, J.R.(2011). Racial disparities in breast cancer mortality in a multiethnic cohort in the Southeast. Cancer Oct 15:118: 2693-2699.

Okoronkwo, I.L., Ejike-Okoye, P., Chinweuba, A.U. & Nwaneri, A.C., (2015). Financial barriers of utilization of screening and treatment services for breast cancer; An equity analysis in Nigeria. Nigeria Journal of Clinical Practice.;18;287-91.

American cancer society (2016): Cancer Facts and Figures- 2016. Atlanta.

Fulton, J., Heiney, Adams, S.A., Butler, W.M., S.P.,Williams, E.M., Delage, A.F….Herbert, J.R (2011). Racial disparities in breast cancer mortality in multi ethnic cohort in south east. Cancer Journal118(10).2693-2699.

Ziller, V., Kalder, M. & Albert, U.S.(2013). Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer. Annual Oncology;20:431–436.

Walters, V., French, S.E., Lenton, R., & Eyles, J. (2010). An empirical evaluation of an expanded Nursing Stress Scale. Journal of Nursing Measurement. 8(2):161-78.

Abdul Hadi, M., Hassali, M.A.& Shafie, A.A.(2009). Knowledge and perception of breast cancer among women of various ethnic groups in the state of pregnancy. A cross sectional survey. Med princ pract.;19:61-61.

Michaud, L.B., & Choi, S.(2008). Oral chemotherapy: A shifting paradigm affecting patient safety. HemOnc Today

Ruddy, K., Mayer, E. & Patridge, A. (2010). Patients adherence and persistence with oral anticancer treatment: A cancer journal for clinicians. 59 (1):56.

Lebovotis, A.H. (2007). The psychological assessment of chronic pain patients: Current review of pain.4:122-6.

Thompson, A.M., Mc Cowan, Dewar, J. A. & Fahey, T.P.(2007). Tamoxifen adherence and its relationship to mortality in women with breast cancer. 164-164.DOI:10.1016/S1359-6349(07)70694-8.

Adewale, O., Adisa,Oladejo, O., Lawal Abdul Rasheed, K. & Adesunkanmi.(2009). Breast cancer in Nigeria: Is non-adherence to chemotherapy schedules a major factor in the reported poor treatment outcome DOI: 10.1111/.1524-4741.

Smith, A., Wandless, I.& Mucklow, J.C. (2013). Compliance with prescribed medicines: a study of elderly patients in the community. J R Coll Gen Pract.29(204):391-396.

Sabaté, E. (2009). Adherence to long-term therapies: evidence for action. Geneva: World Health Organization.

Claxton, A.J., Cramer, J. & Pierce, C.A. (2010). Systematic review of the associations between dose regimens and medication compliance. Clinical Therapeutics.23:1296–1310.

Kruse, W., Rampmaier, J.& Ullrich, G. (2014). Patterns of drug compliance with medications to be taken once and twice daily assessed by continuous electronic monitoring in primary care. International Journal of Clinical Pharmacology Therapy; 32: 452–457.

Jimmy & Jimmy Jose. (2011): Patient medication adherence: Measures in daily practice. Oman medical Journal.26(3):155-159.

World Health Organization WHO (2003). Breast cancer; prevention and control.

Dawn, L., Hershman, L., Lawrence, H., Kushi, T., Theresa, S., Donna, B., Aaron, K., Wei-Yann, T., Louis, F., Scarlett, L., Sunita, M., Alfred, I. (2010). Early discontinuation and non adherence to adjuvant chemotherapy in a cohort of 8, 769 cancer patients. Journal of Clinical Oncology.; 28(27) 4120-4127.

Adewale, O., Adisa,Oladejo, O., Lawal Abdul Rasheed, K. & Adesunkanmi.(2009). Breast cancer in Nigeria: Is non-adherence to chemotherapy schedules a major factor in the reported poor treatment outcome DOI: 10.1111/.1524-4741.

Anyanwu, S.N., Egwuonu, O.A. & Ihekwoaba, E.C. (2011). Acceptance and adherence to treatment among breast cancer patients in Eastern Nigeria. Breast. 20Suppl2:s51-53.

Atkins, L. & Fallowfield, L. (2006). Intentional and non intentional non adherence to medication among breast cancer patients. European Journal of Cancer, 42,2271-2276.

Schenider -Susan, M., Hess- Kimberly & Gosselin, T. (2011). Intervention to promote adherence with oral agents. Seminars in Oncology nursing.27:133-141.

Kelloway, J.S., Wyatt, R.A. & Adlis, S.A.(2014) Comparison of patients’ compliance with prescribed oral and inhaled asthma medications. Arch Intern Med.;154:1349–52.

Ponnusankar, S., Surulivelrajan, M. & Anandamoorthy, N. (2012). Assessment of impact of medication counseling on patients’ medication knowledge and compliance in an outpatient clinic in South India. Patient Education and Counsultation.;54:55–60.

Lawson, V.L., Lyne, P.A.& Harvey, J.N. (2009). Understanding why people with type 1 diabetes do not attend for specialist advice: a qualitative analysis of the views of people with insulin-dependent diabetes who do not attend diabetes clinic. Journal Health Psychology;10:409–23.

Vlasnik, J.J., Aliotta, S.L.& DeLor, B. (2011). Medication adherence: factors influencing compliance with prescribed medication plans. Case Manager.16:47–51.

Lawson, V.L., Lyne, P.A.& Harvey, J.N. (2012). Understanding why people with type 1 diabetes do not attend for specialist advice: a qualitative analysis of the views of people with insulin-dependent diabetes who do not attend diabetes clinic. Journal Health Psychology;10:409–23.

Published
2019-01-01
How to Cite
1.
Ingwu* J, Idoko C, Israel C, Maduakolam I, Madu O. Factors influencing non–adherence to chemotherapy: Perspective of Nigerian breast cancer survivors. NPT. 6(1):453-60.
Section
Original Article(s)